Prevalence, duration and indications for prescribing of antidepressants in primary care
The DOI matches its Crossref record; 8 of the 9 references it cites were found in a registry or an index.
Abstract
SIR—Depression is thought to occur in 10% of the adult population in Britain at any one time [1]. In older people, the incidence of depression rises to 15% [2]. We know that the volume of antidepressants prescribed in English primary care, where most people receive treatment for depression, has increased substantially over recent years [3, 4], but there are no data on the prevalence of antidepressant prescribing at patient level and the extent of continuation of prescribing in individual patients. Guidelines suggest withdrawal of antidepressants after 6 months of effective treatment [5], but long-term prescribing (2 years or more) may be appropriate if the illness is chronic or relapsing. A more worrying reason for long-term prescribing would be difficulty with stopping antidepressants because of unpleasant withdrawal reactions. Patients may also remain on treatment by therapeutic momentum—because the prescriber does not suggest or attempt withdrawal or does not review the continuing need for the medicine. We aimed to identify the frequency of antidepressant prescribing in a typical English Primary Care Trust, how long these medicines were prescribed for and the reasons for long-term prescribing. North Bradford PCT has a population of about 94,000 in a socioeconomically mixed urban and suburban area. The population is predominantly white British. There are 12 general practices, of which 11 (population of 81,221 in 2002) have clinical databases that allow suitable searches and were included in the study. Each practice database was searched for antidepressant prescriptions (acute or repeat) issued in the quarters commencing April 2002 and April 2004. An antidepressant was defined as any drug appearing in British National Formulary (BNF) section 4.3: antidepressants. The 2002 cohort was addressed to identify those being prescribed antidepressants in the quarter commencing April 2004. Separate searches were made for tricyclic antidepressants (TCAs) (BNF section 4.3.1), selective serotonin reuptake inhibitors (SSRIs) (4.3.3) and ‘other antidepressants’ [e.g. venlafaxine (4.3.4)]. For the second phase of the study, we took a sample of 140 patients (representing 5% of those who had been prescribed an antidepressant in both 2002 and 2004) to answer questions about how long patients had been prescribed antidepressants, the reason for prescribing and whether a review occurred. We based our sample size on the proportion of those who been prescribed a TCA, rather than another type of antidepressant. In our population, that rate was 48%. Taking a sample of 140 patients would give a population estimate with 95% confidence intervals within 8% of the actual figure, which we interpreted as being sufficiently accurate. A diagnosis was sought from information in general practitioner records and hospital letters. The number of consultations with the general practitioner over a 2-year period was recorded. Evidence was sought from each consultation as to whether this was for a mental health reason. Evidence was also sought as to whether the patient was under review by a psychiatrist. The first antidepressant ever prescribed for the individual, the final antidepressant prescribed (up to April 2004) and the number of drug or dose changes between these two time periods were recorded. The rates of antidepressant prescribing in 2002 and 2004 are summarised in Table 1. The prescribing rates among the practices did not change between 2002 and 2004. Four per cent of males and 9% females were prescribed an antidepressant in 2004. In total 72% of those prescribed an antidepressant were females. Antidepressant prescribing in 11 general practices: 2002 and 2004 Antidepressant prescribing in 11 general practices: 2002 and 2004 Of those prescribed an antidepressant in 2002, 48% (2,711/5,648) (practice range 33–55%) were still prescribed one in 2004. The continuation rate varied by antidepressant type (TCA 48%, SSRI 36% and ‘other antidepressants’ 45%), with the SSRI rate significantly lower than that of TCAs and ‘other’ (Wilcoxon signed rank test z = 2.93, P = 0.003, and z = 2.76, P = 0.006, respectively). The mean duration of prescribing of antidepressants for those who were prescribed antidepressants in both 2002 and 2004 for different indications ranged from 4.8 to 7.7 years (Table 2). Indication for patients prescribed an antidepressant in both 2002 and 2004 (phase 2 sample) Indication for patients prescribed an antidepressant in both 2002 and 2004 (phase 2 sample) The mean age of the 5% sample (140 patients) was 59 years and 72% (101/140) were female. This compares with 72% in the total population and an average age of 57 years. The mean number of general practitioner consultations was 11 over the 2-year period April 2002 to June 2004 (range 1–53). All subjects had at least one consultation with their general practitioner in the 2-year period. Despite this, 21% (30/140) [22/87 (25%) TCAs and 8/53 (15%) SSRIs] had no documented mental hea
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, the mean duration of antidepressant treatment is longer than two years in the UK (Johnson 2012: Petty 2006), four years in Australia (Kjosavik 2016), and longer than five years in the United States (Mojtabi 2014; Pratt 2011).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Petty 2006
Citations
Cites
The National Institute for Clinical Excellence
(2001) · Nursing Management · doi:10.7748/nm.8.2.39.s15 · Cited by 3,876
Review of community prevalence of depression in later life
Beekman, A. T. F., Copeland, J., & Prince, M. J. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.4.307 · Cited by 1,144
Secular trends in antidepressant prescribing in the UK, 1975-1998
Middleton, N., Gunnell, D., Whitley, E., Dorling, D., & Frankel, S. (2001) · Journal of Public Health · doi:10.1093/pubmed/23.4.262 · Cited by 168
Lawrenson, R., Tyrer, F., Newson, R. B., & Farmer, R. D. T. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00147-0 · Cited by 165
Clinical management of antidepressant discontinuation.
Rosenbaum, J. F., & Zajecka, J. (1997) · PubMed · Cited by 99
Zermansky, A. G. (1996) · Europe PMC (PubMed Central) · Cited by 98
Self-citationAntidepressant drug prescribing among elderly subjects: a population-based study
Percudani, M., Barbui, C., Fortino, I., & Petrovich, L. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1259 · Cited by 50
Natural history of pharmacotherapy of older depressed community residents: The MRC–ALPHA Study
Wilson, K. C. M., Copeland, J. R. M., Taylor, S., & Donoghue, J. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.5.439 · Cited by 29
Cited by
Influences on antidepressant prescribing trends in the UK: 1995–2011
Mars, B., Heron, J., Kessler, D., Davies, N. M., Martin, R. M., Thomas, K. H., & Gunnell, D. (2017) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1306-4 · Cited by 419
“Alternatively, it could reflect failure by GPs to adequately follow-up patients and monitor treatment, with several studies finding that many patients on long-term AD treatment have not had a recent medication review [28, 41].”
BackgroundMoore, M., Yuen, H. M., Dunn, N., Mullee, M. A., Maskell, J., & Kendrick, T. (2009) · BMJ · doi:10.1136/bmj.b3999 · Cited by 287
“Another plausible explanation is that long term repeat prescribing of antidepressants has increased in recent years. A cross sectional survey of general practice records from 2002 and 2004 highlights the relative importance of chronic prescribing.”
BackgroundBogowicz, P., Curtis, H. J., Walker, A. J., Cowen, P., Geddes, J., & Goldacre, B. (2021) · BJGP Open · doi:10.3399/bjgpo.2021.0020 · Cited by 216
“One English study found that 61% of a small sample of those prescribed antidepressants had a diagnosis of depression or mixed depression and anxiety.(13) In one small Scottish study, this figure was 85%.”
BackgroundLuo, Y., Kataoka, Y., Ostinelli, E. G., Cipriani, A., & Furukawa, T. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00035 · Cited by 206
“Although longterm maintenance treatment is recommended for patients with recurrent episodes (10, 12), future studies are required to explore the appropriateness of actual prolonged prescriptions (31, 32).”
BackgroundUnderstanding the prescription of antidepressants: a Qualitative study among French GPs
Mercier, A., Aubin-Auger, I., Lebeau, J., Royen, P. V., & Peremans, L. (2011) · BMC Family Practice · doi:10.1186/1471-2296-12-99 · Cited by 161
“According to the available data, this consumption is supposed to be related to a higher rate of depressed patients in France, an increase in the number of patients treated for depression, and higher demand for medical care [6,7].”
Batelaan, N. M., Bosman, R. C., Muntingh, A., Scholten, W. D., Huijbregts, K. M., & van Balkom, A. J. L. M. (2017) · BMJ · doi:10.1136/bmj.j3927 · Cited by 153
Assessing the social dimension of frailty in old age: A systematic review
Bessa, B., Ribeiro, Ó. M., & Coelho, T. (2018) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2018.06.005 · Cited by 139
Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort study
Johnson, C. F., Macdonald, H. J., Atkinson, P., Buchanan, A. I., Downes, N., & Dougall, N. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x658304 · Cited by 105
Strategies to reduce use of antidepressants
Kendrick, T. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14475 · Cited by 96
“The median duration of use among patients on antidepressants is now more than two years in the UK [11, 12] and more than five years in the USA [13, 14], which is ahead of us in this process of ever-increasing length of treatment.”
BackgroundAmbagtsheer, R. C., Beilby, J. J., Visvanathan, R., Dent, E., Yu, S., & Braunack-Mayer, A. J. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2018.12.020 · Cited by 95
Reid, S., & Barbui, C. (2010) · BMJ · doi:10.1136/bmj.c1468 · Cited by 93
“However, the increase in antidepressant prescribing was not accounted for by new diagnoses but rather a rise in the number of prescriptions given for long term treatment: although the proportion of patients receiving short term treatment declined, the proportion of patients receiving continuing prescriptions for over…”
BackgroundInfluentialVan Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs)
Jannini, T. B., Lorenzo, G. D., Bianciardi, E., Niolu, C., Toscano, M., Ciocca, G., Jannini, E. A., & Siracusano, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210517150418 · Cited by 98
“On average, a consistent number of antidepressants is prescribed by general practitioners (GPs), with most of them being administered for treating depression, and a minority for the treatment of other disorders [13, 14].”
'Doing the right thing': factors influencing GP prescribing of antidepressants and prescribed doses
Johnson, C. F., Williams, B., MacGillivray, S. A., Dougall, N. J., & Maxwell, M. (2017) · BMC Family Practice · doi:10.1186/s12875-017-0643-z · Cited by 86
Mercier, A., Auger-Aubin, I., Lebeau, J.-P., Schuers, M., Boulet, P., Hermil, J.-L., Van Royen, P., & Peremans, L. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-55 · Cited by 81
“Data in various industrialised countries showed similar results [4-7].”
ResultMultinational comparison of new antidepressant use in older adults: a cohort study
Tamblyn, R., Bates, D. W., Buckeridge, D. L., Dixon, W., Forster, A. J., Girard, N., Haas, J., Habib, B., Kurteva, S., Li, J., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027663 · Cited by 76
Deshauer, D., Moher, D., Fergusson, D., Moher, E., Sampson, M., & Grimshaw, J. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071068 · Cited by 78
Bosman, R. C., Huijbregts, K. M., Verhaak, P. F., Ruhé, H. G., van Marwijk, H. W., van Balkom, A. J., & Batelaan, N. M. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x686641 · Cited by 76
Tribl, G. G., Wetter, T. C., & Schredl, M. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.05.001 · Cited by 76
A narrative review of clinical inertia: focus on hypertension
Faria, C., Wenzel, M., Lee, K. W., Coderre, K., Nichols, J., & Belletti, D. A. (2009) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2009.03.001 · Cited by 75
Kendrick, T., Stuart, B. L., Newell, C., Geraghty, A. W. A., & Moore, M. V. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.052 · Cited by 71
Long-term prescribing of antidepressants in the older population: a qualitative study
Dickinson, R., Knapp, P., House, A. O., Dimri, V., Zermansky, A., Petty, D., Holmes, J., & Raynor, D. K. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x483913 · Cited by 66
“A possible reason for long-term prescribing may be patients’ difficulties (actual or anticipated) with discontinuing antidepressant treatment because of unpleasant withdrawal reactions.(8,1) GPs managing late-life depression have articulated several obstacles to its effective management, including a lack of agencies t…”
BackgroundSelf-citationAntidepressant use and risk of adverse outcomes: population-based cohort study
Bansal, N., Hudda, M., Payne, R. A., Smith, D. J., Kessler, D., & Wiles, N. (2022) · BJPsych Open · doi:10.1192/bjo.2022.563 · Cited by 66
Ambresin, G., Palmer, V., Densley, K., Dowrick, C., Gilchrist, G., & Gunn, J. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.055 · Cited by 61
“Another study reported that 21% had no documented mental health review in the previous two year period (Petty et al., 2006).”
BackgroundFrailty and hypertension in older adults: current understanding and future perspectives
Liu, P., Li, Y., Zhang, Y., Mesbah, S. E., Ji, T., & Ma, L. (2020) · Hypertension Research · doi:10.1038/s41440-020-0510-5 · Cited by 57
Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care
Eveleigh, R., Muskens, E., Lucassen, P., Verhaak, P., Spijker, J., van Weel, C., Oude Voshaar, R., & Speckens, A. (2018) · BJGP Open · doi:10.3399/bjgpopen17x101265 · Cited by 51
“An average Dutch general practice (2400 patients) has approximately 50–60 patients using antidepressants longterm,(30) with one-third possibly doing so inappropriately.(8) This study’s recruitment rate was based on the results of three GPs piloting patient recruitment in their practices.”
Eveleigh, R., Speckens, A., van Weel, C., Oude Voshaar, R., & Lucassen, P. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319872344 · Cited by 48
Verhaak, P. F. M., de Beurs, D., & Spreeuwenberg, P. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024051 · Cited by 45
“4 years for anxiety and 5 years for pain.(19) Read et al also reported that 52% of a New Zealand sample continued antidepressant treatment for 3 or more years, with this proportion increasing with age,(20) while Ambresin et al reported that therapy was continued for more than 2 years in 47% of antidepressant users.”
BackgroundAmbagtsheer, R. C., Archibald, M. M., Lawless, M., Kitson, A. A., & Beilby, J. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01551-6 · Cited by 46
Pfaff, J. J., Alfonso, H., Newton, R. U., Sim, M., Flicker, L., & Almeida, O. P. (2014) · British Journal of Sports Medicine · doi:10.1136/bjsports-2013-092510 · Cited by 39
A comparison of antidepressant use in Nova Scotia, Canada and Australia
Smith, A. J., SKETRIS, I. S., Cooke, C., Gardner, D. M., Kisely, S. R., & Tett, S. E. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1541 · Cited by 45
Ma, Y., Balasubramanian, R., Pagoto, S., Schneider, K. L., Culver, A. L., Olendzki, B. C., Tinker, L. F., Liu, S., Safford, M. M., Sepavich, D. M., et al. (2011) · Diabetes Care · doi:10.2337/dc11-1223 · Cited by 43
Zermansky, A. G., & Silcock, J. (2009) · PharmacoEconomics · doi:10.2165/00019053-200927010-00003 · Cited by 38
“Sometimes it is difficult to be sure of the original indication for such drugs,([5]) and the only way to discover whether they are still appropriate may be to stop them (not without trepidation!) and see what happens.”
BackgroundSelf-citationSmith, S. H. L., Reilly, P., & Bull, A. M. J. (2019) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2019.109451 · Cited by 40
Frailty—A promising concept to evaluate disease vulnerability
Ribeiro, A. R., Howlett, S. E., & Fernandes, A. M. A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111217 · Cited by 43
Lunghi, C., Antonazzo, I. C., Burato, S., Raschi, E., Zoffoli, V., Forcesi, E., Sangiorgi, E., Menchetti, M., Roberge, P., & Poluzzi, E. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s241780 · Cited by 41
Haller, E., Watzke, B., Blozik, E., Rosemann, T. J., Reich, O., Huber, C. A., & Wolf, M. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2178-4 · Cited by 39
Ma, Y., Balasubramanian, R., Pagoto, S. L., Schneider, K. L., Hébert, J. R., Phillips, L. S., Goveas, J. S., Culver, A. L., Olendzki, B. C., Beck, J., et al. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301394 · Cited by 29
Bowers, H. M., Williams, S. J., Geraghty, A. W. A., Maund, E., O’brien, W., Leydon, G., May, C. R., & Kendrick, T. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027837 · Cited by 31
Harris, T. J., Carey, I. M., Shah, S. M., DeWilde, S., & Cook, D. G. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.09.005 · Cited by 35
Factors associated with the prescription of antidepressive medication to breast cancer patients
Suppli, N. P., Deltour, I., Damkjær, L., Christensen, J., Jensen, A. B., Kroman, N. T., Johansen, C., & Dalton, S. O. (2011) · Acta Oncologica · doi:10.3109/0284186x.2010.531049 · Cited by 31
Furyk, C., Senthuran, S., Nye, D., Ho, Y. H., & Leicht, A. S. (2021) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2021.650835 · Cited by 31
“A range of tools to identify the clinical syndrome of frailty have been reported and validated over the last several years (27, 45, 46).”
BackgroundMethodInfluential‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants
Leeuwen, E. V., Anthierens, S., van Driel, M., Sutter, A. D., van den Branden, E., & Christiaens, T. (2021) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2021.2006487 · Cited by 30
“years [1,2] and in the US two thirds [3,4].”
BackgroundThe relationship between syncope, depression and anti-depressant use in older adults
Bhangu, J. S., King-Kallimanis, B., Cunningham, C., & Kenny, R. A. (2014) · Age and Ageing · doi:10.1093/ageing/afu003 · Cited by 28
“7% of prescriptions for communitydwelling older people [14, 15].”
BackgroundMultinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication
Tamblyn, R. M., Bates, D. W., Buckeridge, D. L., Dixon, W. G., Girard, N., Haas, J. S., Habib, B., Iqbal, U., Li, J., & Sheppard, T. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16404 · Cited by 29
“However, antidepressant use observed in these more selected populations is similar to that reported for older adults in these countries.(3,54-59) Some potentially important confounders that increase the risk of JAGS JULY 2020-VOL.”
ResultMelo, E. M. D. A., Marques, A. P. D. O., Leal, M. C. C., & Melo, H. M. D. A. (2018) · Saúde em Debate · doi:10.1590/0103-1104201811710 · Cited by 28
Jayasooriya, N., Blackwell, J., Saxena, S., Bottle, A., Petersen, I., Creese, H., Hotopf, M., Pollok, R. C. G., & POP‐IBD study group (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16820 · Cited by 27
“Smoking status n (%) Smoker 1110 (25) 1044 (10) 5506 (9) <0.”
Sinclair, J. E., Aucott, L. S., Lawton, K., Reid, I. C., & Cameron, I. M. (2014) · Family Practice · doi:10.1093/fampra/cmu019 · Cited by 27
Johnson, C. F. A., Dougall, N. J., Williams, B., MacGillivray, S. A., Buchanan, A. I., & Hassett, R. (2014) · BMC Family Practice · doi:10.1186/s12875-014-0210-9 · Cited by 25
“4% [16] and 33 to 55% [10] using slightly different definitions.”
BackgroundPharmaco-epidemiology of antidepressant exposure in a UK cohort record-linkage study
Hafferty, J. D., Wigmore, E. M., Howard, D. M., Adams, M. J., Clarke, T., Campbell, A., MacIntyre, D. J., Nicodemus, K. K., Lawrie, S. M., Porteous, D. J., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119827888 · Cited by 24
“…et al., 2015; Huijbregts et al., 2017; Ilyas and Moncrieff, 2012; Kendrick et al., 2015; Lockhart and Guthrie, 2011; Mars et al., 2017; Meijer et al., 2004; Mojtabai and Olfson, 2014; Moore et al., 2009; MunozArroyo et al., 2006; Olfson and Marcus, 2009; Petty et al., 2006; Raymond et al., 2007).”
InfluentialBobo, W. V., Grossardt, B. R., Lapid, M. I., Leung, J. G., Stoppel, C. J., Takahashi, P. Y., Hoel, R. W., Chang, Z., Lachner, C., Chauhan, M., et al. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.461 · Cited by 23
“Our findings are thus consistent with previous studies documenting the use of antidepressants for mild or poorly defined mental health conditions or unspecified psychiatric or somatic symptoms.(4,20,37,38) Bereavement and adjustment disorder diagnoses can be quite severe and at times difficult to distinguish from majo…”
ResultBergen, H. A., Murphy, E., Cooper, J., Kapur, N., Stalker, C., Waters, K., & Hawton, K. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.10.004 · Cited by 19
Brains, Bones, and Aging: Psychotropic Medications and Bone Health Among Older Adults
Brown, M. J., & Mezuk, B. R. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-012-0121-4 · Cited by 20
“Most psychotropic medications are prescribed in primary care, particularly for older adults [87], and in this setting there is the increased potential for a mismatch between physicians’ intent and practice in prescribing [88–90].”
BackgroundScholten, W., Batelaan, N., & Van Balkom, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320933404 · Cited by 17
Cognitive Frailty as a Predictor of Mortality in Older Adults: A Longitudinal Study in Peru
Young, D. A. V. T., Salazar-Talla, L., Cuba-Ruiz, S., Urrunaga‐Pastor, D., Runzer-Colmenares, F. M., & Parodi, J. F. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.910005 · Cited by 18
“(1) Exhaustion: defined using the following questions from the geriatric depression scale (35, 36): (a) Do you feel full of energy?; (b) Do you feel that you cannot go on?; (c) Do you feel that everything you do is an effort? Exhaustion was considered with two or more positive responses (37); (2) Weight loss: defined…”
MethodSSRI-associated optic neuropathy
Lochhead, J. (2015) · Eye · doi:10.1038/eye.2015.119 · Cited by 17
Blackwell, J., Saxena, S. K., Jayasooriya, N., Petersen, I., Hotopf, M. H., Creese, H., Bottle, A., & Pollok, R. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.12.026 · Cited by 16
Factors associated with the risk for falls in PACE participants
McKay, M. A., Todd-Magel, C., & Copel, L. C. (2020) · Geriatric Nursing · doi:10.1016/j.gerinurse.2020.03.002 · Cited by 18
Cezar, N. O. D. C., Aprahamian, I., Ansai, J. H., de Oliveira, M. P. B., da Silva, D. C. P., Gomes, W. D. L., Barreiros, B. A., Langelli, T. D. C. O., & de Andrade, L. P. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111390 · Cited by 16
Chen, J., Shih, H.-S., Tu, J., Chiou, J., Chang, S.-H., Hsu, W., Lai, L., Chen, T., & Chen, Y. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215111 · Cited by 17
“These vascular factors may increase the risk of stroke, and if the affected area is related to language, the ability of verbal fluency is then affected [55, 56].”
Fluoxetine vs placebo for depressive symptoms after stroke: failed randomised controlled trial
Ruddell, M. E., Spencer, A., Hill, K. M., & House, A. O. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1771 · Cited by 16
“Prompted by our experience in this trial we have recently undertaken a primary care-based study of antidepressant prescribing (Petty et al., 2006) that showed 15% of adults aged> 75 years are in receipt of an antidepressant prescription from their general practitioner––half of them for more than 2…”
Self-citationBlackwell, J., Alexakis, C., Saxena, S. K., Creese, H., Bottle, A., Petersen, I., Hotopf, M. H., & Pollok, R. (2021) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2020-000588 · Cited by 18
“Clinicians should consider ADM use a flag for potentially worse clinical outcomes in the natural history of UC.”
Sigvardsen, P. E., Fosbøl, E. L., Jørgensen, A., Torp-Pedersen, C., Køber, L., & Kofoed, K. F. (2025) · The Lancet Public Health · doi:10.1016/s2468-2667(25)00073-8 · Cited by 14
Rajendiran, N., & Thulasidhasan, J. (2016) · Luminescence · doi:10.1002/bio.3126 · Cited by 14
“Luminescence 2016: 1–10 Copyright © 2016 John by their therapeutic use for depressive disorders but also by their use in a variety of diseases that have an effect on mental state – such as insomnia, anxiety disorder, post-traumatic stress disorder, obsessive compulsive disorder, and chronic pain (7,8).”
BackgroundLeeuwen, E. V., Maund, E., Woods, C. J., Bowers, H. M., Christiaens, T., & Kendrick, T. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.04.060 · Cited by 14
Wentink, C., Huijbers, M. J., Lucassen, P. L., Kramers, C., Akkermans, R., Adang, E., Spijker, J., & Speckens, A. E. M. (2019) · BMC Family Practice · doi:10.1186/s12875-019-0989-5 · Cited by 15
Cochrane, S. K., Dale, A. M., Buckner‐Petty, S., Sobel, A. D., Lippold, B., & Calfee, R. P. (2020) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2020.10.012 · Cited by 13
Ambagtsheer, R. C., Casey, M. G., Lawless, M., Archibald, M. M., Yu, S., Kitson, A. A., & Beilby, J. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01778-9 · Cited by 12
Vasquez-Goñi, G. A. J., Romero, B. M. P., Urrunaga‐Pastor, D., Runzer-Colmenares, F. M., & Parodi, J. F. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08640 · Cited by 12
Gasse, C., Petersen, L. V., Chollet, J., & Saragoussi, D. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.08.015 · Cited by 12
Lippold, B., Tarkunde, Y. R., Cheng, A. L., Hannon, C. P., Adelani, M. A., & Calfee, R. P. (2022) · Arthroplasty Today · doi:10.1016/j.artd.2022.01.032 · Cited by 10
A systematic review and meta‐analysis of frailty in patients with heart failure
Chen, X., & Meng, X. (2024) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.14192 · Cited by 9
Luo, Y., Kataoka, Y., Ostinelli, E. G., Cipriani, A., & Furukawa, T. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00171 · Cited by 8
Antidepressant use and associated factors among the elderly: the Bambuí Project
Vicente, A. R. T., Costa, E., Diniz, B. S., Firmo, J. O. A., Lima‐Costa, M. F., & Filho, A. I. D. L. (2015) · Ciência & Saúde Coletiva · doi:10.1590/1413-812320152012.09662015 · Cited by 7
Factors associated with health-related quality of life in PACE participants
McKay, M. A., & Copel, L. C. (2021) · Geriatric Nursing · doi:10.1016/j.gerinurse.2020.12.011 · Cited by 5
Oscar, M. M., Boland, M., & Cadogan, C. A. (2025) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2025.06.107 · Cited by 4
Knapp, P. (2010) · Wiley eBooks · doi:10.1002/9781444318838.ch9 · Cited by 7
Self-citationImproving the safety of junior doctors' prescribing - systems, skills, attitudes and behaviours
Coombes, I. (2007) · The University of Queensland · doi:10.14264/151484 · Cited by 4
Keep an eye on the SSRI: help avoid possible sight-threatening adverse events
Lochhead, J. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x683641 · Cited by 3
Why we need to evaluate long-term antidepressant use in older patients with depression
Batelaan, N. M., Scholten, W., Rhebergen, D., & van Balkom, A. J. L. M. (2020) · Age and Ageing · doi:10.1093/ageing/afaa286 · Cited by 5
Preoperative Considerations for the Frail Patient
McCarthy, L., Haran, E., Ahern, D. P., McDonnell, J. M., & Butler, J. S. (2021) · Clinical Spine Surgery A Spine Publication · doi:10.1097/bsd.0000000000001283 · Cited by 3
Alhulwah, L. M., Al-Hathloul, A. M., Alblowi, A. S., & Alyahya, K. M. (2011) · Saudi Medical Journal · doi:10.15537/1658-3175.5399 · Cited by 3
“32 (10) Antidepressants prescribing at Riyadh Military Hospital .”
BackgroundDewar-Haggart, R., Müller, I., Bishop, F. L., Geraghty, A. W. A., Stuart, B. L., & Kendrick, T. (2025) · PLoS ONE · doi:10.1371/journal.pone.0299676 · Cited by 3
“Participants self-reported a median continuous antidepressant treatment duration of 11 years, which is considerably higher than the average reported length of treatment in previous research [22,93,94].”
Xu, W., Xiang, Y., & Lyu, J. (2026) · BMC Nephrology · doi:10.1186/s12882-026-04897-y · Cited by 3
Primary Mental Health Care Part 1: A Critical Review of the Irish System
Smith, L. (2021) · doi:10.53902/jpssr.2021.01.000508 · Cited by 3
Case-based learning: safe withdrawal and tapering of antidepressants
(2023) · Pharmaceutical journal/The pharmaceutical journal · doi:10.1211/pj.2023.1.196471 · Cited by 2
Carvalho, A., Palma, V. C., & Tomás, M. T. (2025) · Physical & Occupational Therapy In Geriatrics · doi:10.1080/02703181.2025.2582063 · Cited by 2
Frailty in acute coronary syndrome: From risk stratification to clinical decision-making
Dimitriadou, I., Fradelos, Ε. C., Skoularigis, J. S., Toska, A. G., & Saridi, M. (2026) · World Journal of Cardiology · doi:10.4330/wjc.v18.i1.113258 · Cited by 1
Meier, F., Kontekakis, A., & Schöffski, O. (2012) · PharmacoEconomics German Research Articles · doi:10.1007/bf03320779 · Cited by 1
Emotional and Cognitive Changes Following a Stroke
Knapp, P., & Lightbody, C. E. (2019) · Wiley eBooks · doi:10.1002/9781119581161.ch11 · Cited by 1
Self-citationInamura, N., & Kaneko, T. (2024) · Global Journal of Health Science · doi:10.5539/gjhs.v16n4p32 · Cited by 2
“To date, different scales have been designed to measure frailty [e.g., the Canadian Study of Health and Aging Clinical Frailty Scale (Rockwood et al., 2005), the Edmonton Frail Scale (Petty et al., 2006), and the Tilburg Frailty Indicator (Gobbens et al., 2010)], as with the screening tools for oral frailty [e.g., the…”
MethodFactors associated with drug–drug interactions involving citalopram in the UK Biobank
Laplace, B., Wong, W. L. E., Menchetti, M., Ronchi, D. D., Fusar‐Poli, P., Fanelli, G., MNESYS – Mood and Psychosis Sub-Project (Spoke 5), Serretti, A., Lewis, C. M., & Fabbri, C. (2025) · BJPsych Open · doi:10.1192/bjo.2025.10060 · Cited by 1
CONSUMO DE ANTIDEPRESSIVOS ENTRE IDOSOS: EVIDÊNCIAS DO PROJETO BAMBUÍ.
da Saúde, M. (2015)
(2009) · International Journal of Pharmacy Practice · doi:10.1211/096176709789037137
“Although carer and patient views were sought, the economic model did not take these views into account.([1]) Evidence suggests that people with dementia and their carers believe these medicines have a more global effect than cognition and memory.”
InfluentialThe Use of Antidepressant Drugs in Climacteric Syndrome
Mendes, M. C., & de Sá, M. F. S. (2020) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0040-1701457
Shippee, N. D., Hall, K., Zeglin, J., O’Donnell, C. P., & Virnig, B. A. (2011)
Current awareness in geriatric psychiatry
(2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1627
Metadata
- Authors
- Petty, D. R., House, A., Knapp, P., Raynor, T., & Zermansky, A.
- Affiliations
- University of Leeds (GB)
- Corresponding author
- Petty, Duncan Robert
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-11
- Volume
- 35
- Issue
- 5
- Pages
- 523-526
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W2171692621
- Cited by
- 110
- References
- 9
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 3 · 2023: 1 · 2022: 7 · 2021: 14 · 2020: 15 · 2019: 10 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 3 · 2013: 4 · 2012: 5
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Age and Ageing (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- antidepressant prescribing, depression, long-term prescribing, antidepressant discontinuation, selective serotonin reuptake inhibitors, tricyclic antidepressants, venlafaxine, prescription review, primary care, patient information leaflets, prescribing guidelines adherence, England, chronic depression
- MeSH terms
- Aged, Antidepressive Agents, Anxiety, Depression, Drug Utilization, England, Female, Humans, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Pain, Primary Health Care, Drug Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.